Marijuana Expert Witnesses in West Virginia

This expert began his professional career within the field of behavioral health in 1989 while working towards the obtainment of his undergraduate degree in Psychology. Since his graduation in 1991 he has worked in progressively responsible positions within mental/behavioral health, criminogenic, and substance abuse treatment modalities. This expert has served as the Program Director and Primary Therapist for a Long Term Trauma Recovery Program, as the Program Director for a co-authored program providing contracted services to PA DOC, as the Facility and AOD Director of a 185 bed Specialized Community Correctional Facility, and as the Center Director for outpatient centers which include medically assisted treatment service deliveries; to name a few. This expert has worked extensively as a behavioral therapist, from the front line to planning, designing, implementing and administering tailored programs. This expert has extensive experience maintaining full licensure, accreditation, credentialing and certification in various modalities, such as residential and outpatient venues under multiple regulatory bodies (ACA, CARF, DDAP). He has demonstrated a proficiency at managing both large and small staffs, and maintains teaching or practicing certifications in: Critical Incident Stress Management, Rational Emotive Behavioral Therapy and Trauma Therapy. In addition to his full time work, this expert serves as an adjunct professor in the Sociology and Anthropology department of Wilkes University providing instruction to undergraduate students and as part of the Criminal Justice Advisory Board. Additionally, has operated a small private practice providing program development, grant drafting, consultation and evaluation, along with counseling since 1996. This expert received his Master of Health Administration and his BA in Forensic and Clinical Psychology from Wilkes University in 1995 & 1991; respectively. This expert resides in the back mountain area of NEPA, spends his free time involved in his children’s activities, including over a decade and a half of volunteer and leadership positions for the Cub Scouts and Boy Scouts of America, member of the Board of Trustees for his place of worship, coach and mentor for local Youth Soccer programs and as a devoted Husband and Father.

This highly qualified expert has years of experience in assessing, developing and executing regulatory strategies. He is board certified in internal medicine and endocrinology and has been practicing for 34+ years. He received his PhD degree from Washington University and completed his residency training at Yale-New Haven Hospital. He is a fellow of the American College of Physicians and a member of multiple other professional societies, including the Endocrine Society and the American Diabetes Association, which honored him with its "Outstanding Service Award" in 1991. He has published 16+ peer-reviewed journal articles and lectures nationwide. He is the former executive director of global regulatory strategy, policy and safety at Merck Research Laboratories and the former chief of the diabetes program branch at the National Institute of Health. He is also a former consultant in the division of metabolism and endocrine drug products at the FDA. Currently, he is the owner of an individual pharmaceutical/regulatory consulting company in Pennsylvania.

This expert is board certified psychiatrist and addiction specialist, and also is certified by the American Board of Disability Analysts. He is an expert in handling capital, personal injury, loss mitigation, malpractice and negligence cases that involve the use of abused substances (especially, opiates, alcohol, hallucinogens, and stimulants), prescribed pharmacological agents, and in the general field of psychiatric and brain disease. This expert also is a leading neuroscientist and neuropsychopharmacologist. He can provide expert testimony on the effects of different brain states and function, in both health and disease, and their potential association with with legal culpability and liability. He currently serves as the Chairman of the Department of Psychiatry at a leading university in the USA, and has over 12 years experience as Chairman in Psychiatry Departments in the USA. His research focus is in the neuropsychopharmacology of addiction, addiction and pain, pain treatment, impact of genetics on human behavior, the basic, molecular, and the brain imaging sciences related to the functioning of the brain in health, disease and addiction. In recognition of his academic, scholarly and professional achievement, he is a Fellow of the Collegium Internationale Neuro-psychopharmacologicum and a Distinguished Fellow of the American Psychiatric Association. He is the recipient of numerous professional and scientific awards, including the Jack Mendelson Award at the NIH, which is awarded to individuals who have made distinguished contributions to our understanding of the science of addiction. He has an h-index of 46, and 11829 citations of his published work.

A 17-year veteran of the U.S. Food and Drug Administration (FDA), this expert served as the Regulatory Counsel to the Associate Commissioner for Regulatory Affairs, and previously, in scientific, inspectional, compliance and criminal and civil enforcement capacities as an FDA Consumer Safety Officer (CSO), Compliance Officer (CO), a Senior Special Agent (SA) with the Office of Criminal Investigations (OCI) and as an analytical regulatory microbiologist. During his last three years at FDA he spearheaded the agency's integration efforts with Customs and USDA on crosscutting interagency enforcement and operational issues; served as the FDA's point-person in managing the intersection of imports and FDA's new bioterrorism regulations; established joint agency and industry working groups to evaluate counterfeiting and tampering risks to food and drug distribution supply chains; was the agency lead in its strategic planning efforts to reinvent the FDA's import programs; wrote the initial statement of work and acted as program manager over the FDA's new PREDICT, risk-based electronic entry screening system; and directed the development of the FDA's agency-wide Risk-based Import Strategic Plan designed to improve compliance of foods, dietary supplements, drugs, medical devices, cosmetics, and biological products imported into the U.S. As CEO of a FDA consulting firm and Founder of an affiliated law firm, he currently represents domestic and foreign companies of all sizes, assisting them in identifying USDA, FDA, Federal Trade Commission (FTC), Environmental Protection Agency (EPA), and state requirements. He focuses his practice on FDA matters, including but not limited to: matters relating to FDA inspections, FDA criminal, regulatory and administrative enforcement actions for medical devices, drugs, cosmetics, alcohol, tobacco, dietary supplements, and foods.

This highly-qualified expert has her Masters, PhD and postdoctoral training in the area of environmental toxicology. She continues to work in this area, focusing primarily on the long term effects following exposures to halogenated hydrocarbons. In addition, her research activities involve the study of drug metabolism and nuclear hormone receptors. Her teaching activities (to dental, medical, graduate and undergraduate students), encompass the disciplines of toxicology and pharmacology. The focus here is understanding how exposures to certain chemicals (drugs or toxicants) elicit specific effects resulting in either therapeutic benefit or damage to certain tissues and how that impacts overall health.

This expert has been practicing toxicology for over 40 years. She holds a Master of Science in Clinical Chemistry as well as a Ph.D. in Toxicology, and an honorary doctoral degree in Medicine and Surgery from the Faculty of Medicine, University of Helsinki. She serves on the World Anti-Doping Agency's Prohibited List Committee, the National Commission on Forensic Sciences, the Organization of Scientific Area Committee on Toxicology, Transportation Research Board Committee on Alcohol and Other Drugs, and the National Safety Council's Alcohol, Drugs and Impairment Division Executive Board. She was a President of the International Association of Forensic Toxicologists, she is also a former President of the Society of Forensic Toxicologist and past Chair of the Toxicology Section of the American Academy of Forensic Sciences. She has published over 445 peer-reviewed articles and has presented more than 500 abstracts at national and international meetings, and she sits on the Editorial Board of multiple toxicological and chemical journals. She recently retired as Chief of Chemistry and Drug Metabolism, National Institute on Drug Abuse, National Institutes of Health. She serves as an Adjunct Professor at a major medical university. She consults with the US Department of Transportation, NMS Labs, and other diagnostic companies around the world. The journal Clinical Chemistry identified her as an inspiring mind.

This expert has served the Drug Enforcement Administration for 21 years before entering the private sector. He gained a BA in law enforcement administration from Youngstown State University and was a state trooper for the Maryland State Police for 7 years before joining the DEA. At the DEA, he investigated international and domestic crime organizations, seizing millions of dollars in drug-related assets. This expert has been decorated numerous times and has been honored by the Attorney General for his service.

This clinical development and regulatory expert has an M.S and Ph.D. in Pharmacology & Toxicology from West Virginia University. A member of the American Society of Clinical Pharmacology & Therapeutics, he has extensive product development experience in the pharmaceutical field. The expert spent his early career in clinical research roles, including a position as the Director of Clinical Research Operations for Univax Biologics. He has since founded/run a biotech development business and acts as both a Professor and Consultant in his field.

This expert has extensive experience in the security industry, with his work focusing on off-duty police survival, law enforcement, field drug identification kits, investigations, social media intelligence, executive protection, and training standards. He earned his BS in strategic security and protection management from National American University and currently holds several certifications, including professional crime investigator, social media intelligence expert, and body language specialist. He currently holds one patent for a firearm part. He has formerly served as an infantryman in the US Army, a weapons handler for Lockheed Martin, a protective security specialist for International Development Solutions, an executive protection specialist for K17 Security, a police corporal for the United States Department of Defense, and a mobile security operator for GardaWorld Federal Services. Currently, this expert is the owner of a security consultancy in Virginia.

This highly qualified expert has extensive experience in the fields of cancer, biomedical research, pre-clinical animal research and ethics, and drug development, among others. After earning his BS from East Carolina University and his MS from The University of North Carolina at Greensboro, this expert completed his PhD in genetics and molecular biology at The University of North Carolina, Chapel Hill. He also went on to complete his MBA in biosciences management at North Carolina State University. This expert is an active member of the American Association of Immunologists, the Society for Leukocyte Biology, and the American Association for Cancer Research. In addition to being extensively published, he is the current associate editor of Frontiers in Immunology and Frontiers in Microbiology. Further, this expert has been engaged in a variety of university program development and research operations leadership roles throughout his career. Among his former roles, he has served as a research analyst with the Center for Human Genetics at Duke University Medical Center, a research associate for microbiology and immunology at The University of North Carolina Chapel Hill, and as an assistant professor of inflammatory diseases at Virginia-Maryland College of Veterinary Medicine. This expert currently maintains two assistant professorships at a public medical school in Virginia, in addition to his primary role as an associate professor of inflammatory diseases at a veterinary medicine education school.

This highly qualified expert is specialized in the color and cosmetics chemistry with a deep understanding of formulation, toxicology, microbiology, and the safety requirements of products within his field. He spent 34 years with the Food and Drug Administration where he held a number of positions including serving as the chief of color technology, deputy director of color and cosmetics, and director of applied research and safety assessment at CFSAN. He also served as the director of cosmetic chemistry at The Cosmetic, Toiletry and Fragrance Association and as the executive vice president of science at The Personal Care Products Council. Currently, this expert is an independent advisor of a consulting group in Virginia.

This highly-qualified expert has nearly 45 years of experience in pharmacology. He specializes in pediatric clinical pharmacology, toxicology, and clinical pharmacy, as well as adverse drug reactions, drug-drug-food interactions, pharmacokinetics-pharmacodynamics, and pharmacogenomics. He earned both his BS in pharmacy and his PharmD from the University of Cincinnati. He also completed an internship in community pharmacy at Winston Place Pharmacy, an internship in hospital pharmacy at Holmes Hospital, and a residency in pediatric clinical pharmacy and clinical pharmacology at Children's Hospital Medical Center. This expert is board certified in applied pharmacology by the American Board of Clinical Pharmacology. He is active in his field as a member of the American Society of Hospital Pharmacists and the American College of Clinical Pharmacology. He has formerly served as the co-director of pediatric clinical pharmacology and toxicology at Rainbow Babies and Children's Hospital and the director of the clinical research center at Akron Children's Hospital. Additionally, he has held a variety of teaching positions, including as a tenured professor of pediatrics in the division of pediatric pharmacology and critical care at Case Western Reserve University and as a professor of pediatrics at Northeast Ohio Medical University. Currently, this expert is a professor emeritus of pediatrics at an Ohio university.

This expert is an internationally recognized human resources expert and is a trained Ohio Drug Free Workplace trainer. She earned a JD from Taft Law School and a MBA from York College of Pennsylvania. She is well published on human resources issues, specifically relating to employment practices. She has served as the HR Vice President or Director for a number of large, for-profit and non-profit corporations and is currently the head of Human Resources for a major psychiatric institution.